611 related articles for article (PubMed ID: 34918245)
21. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
[TBL] [Abstract][Full Text] [Related]
22. Rational design of polymer-based particulate vaccine adjuvants.
Huete-Carrasco J; Lynch RI; Ward RW; Lavelle EC
Eur J Immunol; 2024 Feb; 54(2):e2350512. PubMed ID: 37994660
[TBL] [Abstract][Full Text] [Related]
23. [Composition and mode of action of adjuvants in licensed viral vaccines].
Wagner R; Hildt E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Apr; 62(4):462-471. PubMed ID: 30830257
[TBL] [Abstract][Full Text] [Related]
24. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant for H9N2 vaccine to improve immune responses in chickens compared to Alum and oil-based adjuvants.
Gu P; Wusiman A; Zhang Y; Cai G; Xu S; Zhu S; Liu Z; Hu Y; Liu J; Wang D
Vet Microbiol; 2020 Dec; 251():108894. PubMed ID: 33096470
[TBL] [Abstract][Full Text] [Related]
25. Novel Adjuvants and Immunomodulators for Veterinary Vaccines.
Heegaard PM; Fang Y; Jungersen G
Methods Mol Biol; 2016; 1349():63-82. PubMed ID: 26458830
[TBL] [Abstract][Full Text] [Related]
26. New-age vaccine adjuvants, their development, and future perspective.
Verma SK; Mahajan P; Singh NK; Gupta A; Aggarwal R; Rappuoli R; Johri AK
Front Immunol; 2023; 14():1043109. PubMed ID: 36911719
[TBL] [Abstract][Full Text] [Related]
27. Vaccine adjuvants: mechanisms and platforms.
Zhao T; Cai Y; Jiang Y; He X; Wei Y; Yu Y; Tian X
Signal Transduct Target Ther; 2023 Jul; 8(1):283. PubMed ID: 37468460
[TBL] [Abstract][Full Text] [Related]
28. Polysaccharides derived from Chinese medicinal herbs: A promising choice of vaccine adjuvants.
Wan X; Yin Y; Zhou C; Hou L; Cui Q; Zhang X; Cai X; Wang Y; Wang L; Tian J
Carbohydr Polym; 2022 Jan; 276():118739. PubMed ID: 34823775
[TBL] [Abstract][Full Text] [Related]
29. Polysaccharides as vaccine adjuvants.
Sun B; Yu S; Zhao D; Guo S; Wang X; Zhao K
Vaccine; 2018 Aug; 36(35):5226-5234. PubMed ID: 30057282
[TBL] [Abstract][Full Text] [Related]
30. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
31. Laser vaccine adjuvants: Light-augmented immune responses.
Maki Y; Kashiwagi S; Kimizuka Y
Vaccine; 2021 Nov; 39(46):6805-6812. PubMed ID: 34666921
[TBL] [Abstract][Full Text] [Related]
32. An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
Hauser MI; Muscatello DJ; Soh ACY; Dwyer DE; Turner RM
Vaccine; 2019 Jul; 37(31):4246-4255. PubMed ID: 31253447
[TBL] [Abstract][Full Text] [Related]
33. Vaccine adjuvants: Tailoring innate recognition to send the right message.
Lavelle EC; McEntee CP
Immunity; 2024 Apr; 57(4):772-789. PubMed ID: 38599170
[TBL] [Abstract][Full Text] [Related]
34. Trends in vaccine adjuvants.
Schijns VE; Lavelle EC
Expert Rev Vaccines; 2011 Apr; 10(4):539-50. PubMed ID: 21506650
[TBL] [Abstract][Full Text] [Related]
35. Adjuvanted influenza vaccines.
Tregoning JS; Russell RF; Kinnear E
Hum Vaccin Immunother; 2018 Mar; 14(3):550-564. PubMed ID: 29232151
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant system AS01: helping to overcome the challenges of modern vaccines.
Didierlaurent AM; Laupèze B; Di Pasquale A; Hergli N; Collignon C; Garçon N
Expert Rev Vaccines; 2017 Jan; 16(1):55-63. PubMed ID: 27448771
[TBL] [Abstract][Full Text] [Related]
37. Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.
Cuzzubbo S; Mangsbo S; Nagarajan D; Habra K; Pockley AG; McArdle SEB
Front Immunol; 2020; 11():615240. PubMed ID: 33679703
[TBL] [Abstract][Full Text] [Related]
38. Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines.
Ou B; Yang Y; Lv H; Lin X; Zhang M
BioDrugs; 2023 Mar; 37(2):143-180. PubMed ID: 36607488
[TBL] [Abstract][Full Text] [Related]
39. Recent developments in vaccine delivery systems.
O'Hagan DT
Curr Drug Targets Infect Disord; 2001 Nov; 1(3):273-86. PubMed ID: 12455401
[TBL] [Abstract][Full Text] [Related]
40. Toward precision adjuvants: optimizing science and safety.
Nanishi E; Dowling DJ; Levy O
Curr Opin Pediatr; 2020 Feb; 32(1):125-138. PubMed ID: 31904601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]